SUVEN PHARMACEUTICALS
Back to Balance Sheet
|
SUVEN PHARMACEUTICALS Last 5 Year Total Current Liabilities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Total Current Liabilities | ₹365 Cr | ₹117 Cr | ₹303 Cr | ₹348 Cr | ₹322 Cr |
What is the latest Total Current Liabilities ratio of SUVEN PHARMACEUTICALS ?
| Year | Total Current Liabilities |
|---|---|
| Mar2025 | ₹365 Cr |
| Mar2024 | ₹117 Cr |
| Mar2023 | ₹303 Cr |
| Mar2022 | ₹348 Cr |
| Mar2021 | ₹322 Cr |
How is Total Current Liabilities of SUVEN PHARMACEUTICALS Trending?
| Years | Total Current Liabilities | % Change | |
|---|---|---|---|
| Mar2025 | ₹365 Cr | 211.06 | |
| Mar2024 | ₹117 Cr | -61.27 | |
| Mar2023 | ₹303 Cr | -12.79 | |
| Mar2022 | ₹348 Cr | 8.09 | |
| Mar2021 | ₹322 Cr | - | |
Compare Total Current Liabilities of peers of SUVEN PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| SUVEN PHARMACEUTICALS | ₹16,191.6 Cr | -11.6% | 18.6% | -58.1% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,075.0 Cr | 0.4% | 10.8% | 10.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹179,486.0 Cr | 0.7% | 9.5% | 16.5% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹149,124.0 Cr | -2.5% | 6% | 36.2% | Stock Analytics | |
| CIPLA | ₹115,641.0 Cr | 9.7% | 16.7% | -4.9% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹111,589.0 Cr | 4.5% | 9.7% | 9% | Stock Analytics | |
SUVEN PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| SUVEN PHARMACEUTICALS | -11.6% |
18.6% |
-58.1% |
| SENSEX | -2.7% |
-2.1% |
-5.3% |
You may also like the below Video Courses